These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins? Lakatos PL, Altorjay I, Mándi Y, Lakatos L, Tumpek J, Kovacs A, Molnar T, Tulassay Z, Miheller P, Palatka K, Szamosi T, Fischer S, Papp J, Hungarian IBD Study Group, Papp M. Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186 [Abstract] [Full Text] [Related]
3. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J, Hungarian IBD Study Group, Lakatos PL. Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801 [Abstract] [Full Text] [Related]
4. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS. Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856 [Abstract] [Full Text] [Related]
5. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort. Malickova K, Lakatos PL, Bortlik M, Komarek V, Janatkova I, Lukas M. Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001 [Abstract] [Full Text] [Related]
6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [Abstract] [Full Text] [Related]
7. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman GL, Altstock RT, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S. Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509 [Abstract] [Full Text] [Related]